Wegovy Side Effects: What Happens in Your Body and When to Act

Which side effects does Wegovy actually cause most often?

The side effects people encounter most frequently on Wegovy are gastrointestinal. In the STEP 1 trial — one of the pivotal studies submitted for the UK licence — semaglutide 2.4mg produced average weight loss of around 15% over 68 weeks, and the most common reasons people reported discomfort were nausea, diarrhoea, vomiting, constipation, and stomach pain or indigestion. Burping and reflux are reported too, and some people notice fatigue or headaches, particularly in the early weeks. The NHS's semaglutide medicine page lists these in plain language and is worth bookmarking alongside your Patient Information Leaflet.

There is a misconception worth addressing gently: some people assume that if side effects are mild, it means the medicine is not working. That simply is not how semaglutide functions. The absence of nausea does not signal failure; tolerance varies enormously between people, and some find the early weeks genuinely manageable. The gradual titration schedule (doses stepping up roughly every four weeks under prescriber oversight) is designed precisely to reduce the severity and give your system time to settle.

Injection-site reactions can also occur: redness, itching or mild swelling at the point of injection. Rotating sites between the abdomen, thigh and upper arm usually keeps these to a minimum. If you are curious about how semaglutide's effects work across the body beyond the gut, that question is covered separately.

When do Wegovy's side effects become something to act on urgently?

Most gut symptoms are unpleasant rather than dangerous, but a few presentations need prompt medical attention. The clearest one is severe abdominal pain that does not pass and may radiate through to the back, with or without vomiting. This pattern can indicate acute pancreatitis, which is a known but uncommon side effect. In January 2026 the MHRA issued a Drug Safety Update on GLP-1 receptor agonist medicines specifically to remind both patients and clinicians to take this symptom seriously, not to alarm people, but because early recognition matters.

Other presentations worth reporting without delay include signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing), symptoms of gallbladder problems (pain in the upper right abdomen, sometimes with fever or jaundice), or signs that repeated vomiting and diarrhoea have led to dehydration. Dizziness, dark urine and reduced urination are pointers there. If you feel low mood, anxiety or any thoughts of self-harm, stop and contact a healthcare professional or call 111. These are listed in the product literature as effects that have been reported, though causality in individuals is hard to establish.

You can and should report any suspected side effect via the Yellow Card scheme at yellowcard.mhra.gov.uk. That data helps the MHRA monitor the real-world safety profile of medicines once they are in widespread use.

Do the side effects of Wegovy differ at higher doses?

In short, yes. The clinical data consistently show that GI side effects are most common at the start of treatment and after each dose step. When semaglutide moves from 1.7mg to 2.4mg (the previous standard maintenance dose) some people experience a temporary return of nausea or digestive disruption. The same pattern applies to the 7.2mg dose, which the MHRA approved in April 2026. Trials at that higher maintenance level reported around 20.7% average weight loss over 72 weeks, and the side-effect profile is similar in character to lower doses but may be more pronounced for some people during the adjustment period.

For a fuller picture of how Wegovy affects the body at each stage, or specifically how semaglutide acts on appetite signals in the brain, those topics are covered in detail on their own pages. If you are weighing up Wegovy against other options, the weight-loss treatment overview sets out the licensed choices side by side. Cost is a practical consideration too, the Wegovy pricing page explains what private treatment typically involves, without any surprises.

What can you do to reduce Wegovy's side effects day to day?

A few practical habits consistently come up when prescribers talk through Wegovy with patients. Eating smaller portions, chewing slowly and avoiding high-fat or spicy meals during the adjustment period all reduce the likelihood of nausea. Staying well hydrated matters, particularly if diarrhoea is a problem. Most people find that eating a light meal before injecting rather than on an empty stomach makes a difference, though the Patient Information Leaflet and your prescriber's advice always take precedence over general patterns like this.

Timing also helps: some people find that injecting in the evening means the peak of any nausea passes during sleep. That is not a clinical recommendation, just something worth discussing with your prescriber if mornings are rough. The effects on the menstrual cycle are a question many women ask, the evidence on Wegovy and periods is explored separately, including what is known and what remains uncertain.

If side effects are persisting in a way that concerns you, or if you are unsure whether what you are experiencing is typical, the right move is to speak to a prescriber rather than push through alone. At nume, our prescribers are available seven days a week for exactly this kind of aftercare. You can also read more about what happens after stopping semaglutide, or explore the broader semaglutide overview for context. When you are ready to discuss whether Wegovy is right for you, speak to our prescribers through a free consultation.